Cargando…
Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period
Lambert–Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) of more than 10 years is rare. We report a patient who had a recurrence of both SCLC and LEMS...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930592/ https://www.ncbi.nlm.nih.gov/pubmed/27370896 http://dx.doi.org/10.1186/s40880-016-0127-x |
_version_ | 1782440766840242176 |
---|---|
author | Asano, Fumio Watanabe, Keisuke Shinkai, Masaharu Tei, Yoshitaka Mishina, Kei Tanabe, Mikiko Ishii, Hiroshi Shinoda, Masahiro Shimokawaji, Tadasuke Kudo, Makoto Kaneko, Takeshi |
author_facet | Asano, Fumio Watanabe, Keisuke Shinkai, Masaharu Tei, Yoshitaka Mishina, Kei Tanabe, Mikiko Ishii, Hiroshi Shinoda, Masahiro Shimokawaji, Tadasuke Kudo, Makoto Kaneko, Takeshi |
author_sort | Asano, Fumio |
collection | PubMed |
description | Lambert–Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) of more than 10 years is rare. We report a patient who had a recurrence of both SCLC and LEMS after a 13-year DFS period. A 69-year-old man was diagnosed with LEMS and SCLC (cT0N2M0, stage IIIA) 13 years ago. Chemoradiotherapy was performed and a complete response was achieved. With anticancer treatment, the LEMS symptoms was alleviated. At the age of 82 years, gait disturbance appeared followed by left supraclavicular lymphadenopathy and further examination revealed the recurrence of SCLC. Careful screening for the recurrence of SCLC might be needed when the patient has recurrent or secondary paraneoplastic neurological syndrome even after a long DFS period. |
format | Online Article Text |
id | pubmed-4930592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49305922016-07-06 Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period Asano, Fumio Watanabe, Keisuke Shinkai, Masaharu Tei, Yoshitaka Mishina, Kei Tanabe, Mikiko Ishii, Hiroshi Shinoda, Masahiro Shimokawaji, Tadasuke Kudo, Makoto Kaneko, Takeshi Chin J Cancer Case Report Lambert–Eaton myasthenic syndrome (LEMS) is a paraneoplastic syndrome and only 3% of small cell lung carcinoma (SCLC) patients have LEMS. Moreover, the recurrence of SCLC after a disease-free survival (DFS) of more than 10 years is rare. We report a patient who had a recurrence of both SCLC and LEMS after a 13-year DFS period. A 69-year-old man was diagnosed with LEMS and SCLC (cT0N2M0, stage IIIA) 13 years ago. Chemoradiotherapy was performed and a complete response was achieved. With anticancer treatment, the LEMS symptoms was alleviated. At the age of 82 years, gait disturbance appeared followed by left supraclavicular lymphadenopathy and further examination revealed the recurrence of SCLC. Careful screening for the recurrence of SCLC might be needed when the patient has recurrent or secondary paraneoplastic neurological syndrome even after a long DFS period. BioMed Central 2016-07-02 /pmc/articles/PMC4930592/ /pubmed/27370896 http://dx.doi.org/10.1186/s40880-016-0127-x Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Asano, Fumio Watanabe, Keisuke Shinkai, Masaharu Tei, Yoshitaka Mishina, Kei Tanabe, Mikiko Ishii, Hiroshi Shinoda, Masahiro Shimokawaji, Tadasuke Kudo, Makoto Kaneko, Takeshi Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period |
title | Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period |
title_full | Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period |
title_fullStr | Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period |
title_full_unstemmed | Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period |
title_short | Relapse of both small cell lung cancer and Lambert–Eaton myasthenic syndrome after a 13-year disease-free survival period |
title_sort | relapse of both small cell lung cancer and lambert–eaton myasthenic syndrome after a 13-year disease-free survival period |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930592/ https://www.ncbi.nlm.nih.gov/pubmed/27370896 http://dx.doi.org/10.1186/s40880-016-0127-x |
work_keys_str_mv | AT asanofumio relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT watanabekeisuke relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT shinkaimasaharu relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT teiyoshitaka relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT mishinakei relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT tanabemikiko relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT ishiihiroshi relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT shinodamasahiro relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT shimokawajitadasuke relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT kudomakoto relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod AT kanekotakeshi relapseofbothsmallcelllungcancerandlamberteatonmyasthenicsyndromeaftera13yeardiseasefreesurvivalperiod |